Larry Hsu

Dr. Hsu is a successful entrepreneur with >37 years of track record. In addition to LifeMax, Dr. Hsu has co-founded AiViva and currently serves on its board.

​

Prior to LifeMax, he was Co-Founder, President and CEO of Impax Laboratories, a Nasdaq-listed specialty pharmaceutical company. Impax applied its drug development expertise and drug delivery technology to the development , manufacturing and commercialization of specialty pharmaceutical products. Impax established partnership with multiple companies including Teva, AstraZeneca, Pfizer and Shire during his tenure. In the 18 years of its history, Impax grew to a company with more than 1000 employees and a market cap of close to $3 billion when Dr. Hsu retired in 2014.

​

Dr. Hsu worked at Abbott for 15 years before founding Impax. He was the Director of Product Development responsible for worldwide product development, process engineering, clinical supplies manufacturing and production technical support for all dosage forms. He received his Ph.D. degree in Pharmaceutics from University of Michigan and B.S. degree in Pharmacy from National Taiwan University.